METHOD AND SYSTEM FOR MICROBIOME-DERIVED CHARACTERIZATION, DIAGNOSTICS AND THERAPEUTICS FOR CARDIOVASCULAR DISEASE CONDITIONS

Patent №

US 9,754,080

Granted

2017-09-05

Filed 2016

Owner

UBIOME, INC.

Lab

AI components

3

nlp · planning · evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

15098081

A method for at least one of characterizing, diagnosing, and treating a cardiovascular disease condition in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the cardiovascular disease condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the cardiovascular disease condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.

Natural languagePlanningEvolutionary computationG16H 50/20C12Q 1/6883G16B 40/00G16B 40/20G16B 50/00G16B 50/10G16H 10/40G16H 20/30+12 more

AI classification

Planning1.00
Evolutionary computation0.99
Natural language0.79
AI hardware0.09
Machine learning0.08
Knowledge representation0.07
Vision0.01
Speech0.00

Ownership

UBIOME, INC.

assignment · 383840854

Assignors

ALMONACID, DANIEL, APTE, ZACHARY, RICHMAN, JESSICA, BEHBAHANI, SIAVOSH REZVAN

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC